Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
Introduction The last installment of this intervention traced the evolution of AI, reviewed notable developments in its trajectory; its African dimension and policy trend therein and beyond. This week ...
4h
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the Company’s foundations for scalable, innovation-driven growth across AI-enabled ...
Modest improvements for Direct Support Professionals show progress is possible, but also reinforce the need for ...
Vulnerability in the labor market refers to the multidimensional fragility of an individual in the face of the risks of ...
The global race for innovation has entered a new phase. It is no longer driven primarily by countries – or even regions – but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback